MiNK Therapeutics, Inc.INKTNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P20
Within normal range
vs 3Y Ago
-0.2x
Contraction
Streak
3 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -44.84% |
| 2023 | -3.65% |
| 2022 | 69.06% |
| 2021 | 270.11% |
| 2020 | -67.80% |
| 2019 | 0.00% |